Author: Tony Schueth
New POCP Report Examines How States are Addressing Opioid Prescribing, A Root Cause of the Epidemic
By Tony Schueth A first-of-its kind report that details how states are fighting the opioid crisis at the prescription level has been developed by Point of Care Partners (POCP). Unlike …
Why the Focus on Medication Noncompliance?
By Tony Schueth Addressing medication noncompliance is one of the trends we will be seeing in 2018. To be sure, medication noncompliance is a long-standing issue. We have known for …
In Memory of Pharmacy HIT Visionary James D. Lang
This past Saturday there was a memorial service for James D. Lang, PharmD, Vice President of Pharmacy Services at Blue Cross Blue Shield of Michigan (BCBSM), who passed away unexpectedly …
The 21st Century Cures Act and Health IT: A Birds’ Eye View
By Tony Schueth The 21st Century Cures Act is now the law of the land. As you’ve probably heard by now, this bipartisan, $6.3 billion piece of legislation is intended …
5 Ways the Trump Presidency May Impact ONC
In a post on November 14, we laid out our view of the implications of an unexpected Trump victory on healthcare, in general, and health information technology (health IT), specifically …
Reading the Tea Leaves: What Lies Ahead for Health IT in the Trump Administration?
By Tony Schueth, CEO The voters have spoken and there will be a new administration in roughly two months. What does this mean for health information technology (health IT)? Point-of-Care …
Top 10 Takeaways from the MACRA Final Rule
By Tony Schueth The Centers for Medicare and Medicaid Services rolled out the final rule on October 14 for implementing the Medicare Access and CHIP Reauthorization Act (MACRA). It details …
Top 10 Trends at HIMSS16
By Tony Schueth Didn’t make it to HIMSS16 in Vegas? If you did go but couldn’t make it to all the sessions or exhibits, the Point-of-Care Partners team has saved …
Biosimilars 101: Considerations for Health IT and Other Stakeholders
By Tony Schueth Biosimilars now are being introduced in the United States and are expected to rapidly become lower-cost, mainstream treatments for a range of chronic diseases, including cancer, rheumatoid …
©2019 Point of Care Partners | All Rights Reserved
